Swiss Medical Cannabis S.A. is a Swiss company specializing in the production of cannabidiol (CBD)-based medicines. Recently, it invested in artificial intelligence (AI) to respond more effectively to customer queries. The aim of this investment is to provide customers with faster, more accurate information, direct them to the products best suited to their wellness goals, and keep them up to date with scientific advances in CBD.
The beta version of this artificial intelligence has been implemented in our home country, Switzerland, as a first step. The excellent feedback we received from our customers convinced us to give Claire an international dimension.

Reasons for investing in AI

Swiss Medical Cannabis S.A. has decided to invest in artificial intelligence for several reasons. Firstly, it enables us to provide customers with more accurate information more quickly. As a result, customers can quickly benefit from the company's expertise and find the products best suited to their needs.

What's more, this enables us to better guide customers towards the products best suited to their wellness objectives, thus enhancing the customer experience. Indeed, customers have different needs, and the company seeks to provide personalized support.

Finally, it allows us to keep abreast of the latest scientific advances in CBD, and to ensure that customers always have access to the most up-to-date information. It's important for Swiss Medical Cannabis S.A. to stay at the cutting edge of science to give the best possible service to its customers.

Claire, the AI program from Swiss Medical Cannabis S.A.

To achieve this goal, Swiss Medical Cannabis S.A. has created an artificial intelligence program called Claire. This program is accessible via the company's website, and enables customers to ask even the most specific questions about CBD and its derivatives.

Claire has access to the majority of clinical studies conducted on CBD, and uses this knowledge to answer questions and help customers choose the products best suited to their needs. Claire can answer eight out of every 10 questions from our users, and the company is currently working to have Claire answer more questions.

The aim of this program is to offer real-time assistance to Swiss Medical Cannabis S.A. customers. Claire provides customers with an effective and valuable tool to help them better understand the company's products and choose those best suited to their needs.

Swiss Medical Cannabis S.A. website

In addition to investing in artificial intelligence, Swiss Medical Cannabis S.A. is also working to improve the customer experience through its website. The website aims to be a reliable source of information and advice for customers.

The website includes a section on drug interactions with CBD, allowing customers to find out if CBD might interact with their current medications.

This is particularly important for customers taking medication for pre-existing medical conditions who are considering CBD for wellness purposes.

Conclusion

In conclusion, Swiss Medical Cannabis S.A.'s investment in artificial intelligence is an example of how companies can use technology to improve the customer experience and provide accurate, up-to-date information. The creation of Claire, an artificial intelligence program, has enabled the company to better answer customers' questions and direct them to the products best suited to their needs. Combined with the drug interaction information available on the company's website, Swiss Medical Cannabis S.A. continues to work to improve the customer experience and guarantee customer satisfaction.

At Swiss Medical Cannabis S.A., we have been proud to offer superior quality products to our customers for many years. We are committed to providing exceptional customer service, and are delighted to now be able to offer our services to European customers after a period of beta testing. Although we initially developed the Claire AI program to answer questions from our Swiss customers, we are delighted to now be able to offer this incredibly useful tool to all our customers across Europe.

FAQs

1. How can I access Claire, the AI program of Swiss Medical Cannabis S.A.?

You can access Claire by visiting the Swiss Medical Cannabis S.A. website and clicking on the "Questions & Answers" tab.

 2. Does Claire answer all the questions about CBD?

No, Claire does not yet answer all questions about CBD. She can answer eight out of every 10 questions from our users, and the company is currently working on getting Claire to answer more.

3. Does Swiss Medical Cannabis S.A. sell products containing THC?

Swiss Medical Cannabis S.A. does not sell products containing THC. All the company's products are derived from CBD.

4. Does Swiss Medical Cannabis S.A. deliver anywhere in Europe?

Yes, Swiss Medical Cannabis S.A. delivers its products all over Europe.

5. Can I use Swiss Medical Cannabis S.A. products with my current medication?

We advise you to speak to your doctor before using Swiss Medical Cannabis S.A. products if you are already taking medication. You can also read our article on "Drug interactions" on the company's website to learn more about the relationship between CBD and medications.

Perhaps you have more specific questions about CBD and its uses?

Through our articles, we try to answer you:

• Chronic pain
• CBD and sleep disorders
• CBD and anxiety
• CBD and Alzheimer's
• Its action on the endocannabinoid system
• General dosages and tips on taking CBD
• Can CBD help your pets?